24 May 2013
Keywords: GlaxoSmithKline, USA, Tykerb, Lamictal, Approval, Breast cancer, Epilepsy, Employment,
Article | 01 February 2010
UK drug giant GlaxoSmithKline received two pieces of good news from the US Food and Drug Administration last Friday related ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.